As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry ...

AstraZeneca was involved in one of the standout I&I deals of 2025 as it entered into a global strategic collaboration with Harbour BioMed in March that involved an upfront payment, near-term milestone ...

Did you know that chronic obstructive pulmonary disease (COPD) is actually the fourth leading cause of death worldwide? According to the World Health Organization (WHO), the lung disease, which ...

Do you know someone whose competitive streak makes them ace board games? Does this person also geek out about the wonders of the immune system? The Viral board game might be the ideal biotechnology ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...